ATP1A3 Gene Alternating Hemiplegia of Childhood Type 2 NGS Genetic DNA Test
Introduction
The ATP1A3 Gene Alternating Hemiplegia of Childhood Type 2 NGS Genetic DNA Test is a vital diagnostic tool that helps in identifying genetic mutations associated with neurological disorders, specifically Alternating Hemiplegia of Childhood (AHC). This condition is characterized by recurrent episodes of hemiplegia, which can significantly impact a child’s development and quality of life. Understanding the genetic basis of AHC is crucial for effective management and treatment.
What the Test Measures
This test utilizes Next-Generation Sequencing (NGS) technology to detect mutations in the ATP1A3 gene, which plays a critical role in neuronal function. By analyzing the genetic material, healthcare providers can identify specific variations that may contribute to the development of AHC.
Who Should Consider This Test
Parents and guardians should consider this test if their child exhibits symptoms such as:
- Recurrent episodes of weakness or paralysis on one side of the body
- Difficulty with coordination and balance
- Developmental delays or cognitive impairments
- Family history of neurological disorders
Consultation with a neurologist is recommended to assess the need for testing based on clinical symptoms and family history.
Benefits of Taking the Test
- Accurate diagnosis of Alternating Hemiplegia of Childhood
- Informed treatment decisions based on genetic findings
- Potential for early intervention and management strategies
- Understanding the hereditary nature of the condition for family planning
Understanding Your Results
After the test is completed, results will be interpreted by a genetic counselor or neurologist. They will discuss the implications of the findings, including whether a mutation was detected and what it means for the child’s health and treatment options. It is essential to understand that not all genetic variations lead to disease, and professional guidance is crucial in interpreting results.
Test Information
| Test Name | Discount Price | Regular Price |
|---|---|---|
| ATP1A3 Gene Alternating Hemiplegia of Childhood Type 2 NGS Genetic DNA Test | 400,000 NGN | 560,000 NGN |
Book the Test Today!
To gain insights into your child’s neurological health, book the ATP1A3 Gene Alternating Hemiplegia of Childhood Type 2 NGS Genetic DNA Test today. Contact us at +2348110567037 or visit our website to schedule your appointment. Take the first step towards understanding and managing your child’s health.
